Inogen Inc Stock Today
| INGN Stock | USD 7.45 0.43 5.46% |
PerformanceVery Weak
| Odds Of DistressLow
|
Inogen is selling at 7.45 as of the 17th of March 2025; that is 5.46 percent decrease since the beginning of the trading day. The stock's open price was 7.88. Inogen has less than a 10 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Note, on December 13, 2018, Representative Lamar Smith of US Congress acquired under $15k worth of Inogen Inc's common stock.
Business Domain Health Care Equipment & Services | IPO Date 14th of February 2014 | Category Healthcare | Classification Health Care |
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. The company has 26.53 M outstanding shares of which 665.89 K shares are currently shorted by private and institutional investors with about 1.98 trading days to cover. More on Inogen Inc
Moving together with Inogen Stock
Moving against Inogen Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Inogen Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| President | Bart Sanford | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Baby Boomer Prospects, Trump Equities, Obamacare Repeal, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsInogen can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Inogen's financial leverage. It provides some insight into what part of Inogen's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Inogen Inc (INGN) is traded on NASDAQ Exchange in USA. It is located in 859 Ward Drive, Goleta, CA, United States, 93111 and employs 766 people. Inogen is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 197.64 M. Inogen Inc conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 26.53 M outstanding shares of which 665.89 K shares are currently shorted by private and institutional investors with about 1.98 trading days to cover.
Inogen Inc currently holds about 223.62 M in cash with 5.91 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Inogen Probability Of Bankruptcy
Ownership AllocationInogen Inc has a total of 26.53 Million outstanding shares. The majority of Inogen Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Inogen to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Inogen Inc. Please pay attention to any change in the institutional holdings of Inogen Inc as this could imply that something significant has changed or is about to change at the company. On December 13, 2018, Representative Lamar Smith of US Congress acquired under $15k worth of Inogen Inc's common stock.
Check Inogen Ownership Details
Inogen Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| State Street Corp | 2024-12-31 | 524 K | |
| Renaissance Technologies Corp | 2024-12-31 | 492.9 K | |
| Morgan Stanley - Brokerage Accounts | 2024-12-31 | 472.3 K | |
| Aqr Capital Management Llc | 2024-12-31 | 433.7 K | |
| New York State Common Retirement Fund | 2024-12-31 | 410.3 K | |
| Federated Hermes Inc | 2024-12-31 | 404.3 K | |
| Prudential Financial Inc | 2024-12-31 | 360 K | |
| Royce & Associates, Lp | 2024-12-31 | 311.2 K | |
| Jacobs Levy Equity Management, Inc. | 2024-12-31 | 303.5 K | |
| Camber Capital Management Llc | 2024-12-31 | 2 M | |
| Blackrock Inc | 2024-12-31 | 1.7 M |
Inogen Historical Income Statement
Inogen Stock Against Markets
Inogen Corporate Management
| Nabil Shabshab | Pres CEO | Profile | |
| Vijay Paliwal | Senior Enablement | Profile | |
| Adrien Mithalal | Senior Development | Profile | |
| Agnes Lee | VP Planning | Profile | |
| Philip Corrin | Senior Chain | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inogen. If investors know Inogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.873 | Earnings Share (1.52) | Revenue Per Share | Quarterly Revenue Growth 0.055 | Return On Assets |
The market value of Inogen Inc is measured differently than its book value, which is the value of Inogen that is recorded on the company's balance sheet. Investors also form their own opinion of Inogen's value that differs from its market value or its book value, called intrinsic value, which is Inogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inogen's market value can be influenced by many factors that don't directly affect Inogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.